Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cancer and curcumin:

The combination of curcumin and 5-fluorouracil in cancer therapy. Wei Y et al. Arch Pharm Res. (2018)

Curcumin and cancer: barriers to obtaining a health claim. Devassy JG et al. Nutr Rev. (2015)

Curcumin targets in inflammation and cancer. Deguchi A et al. Endocr Metab Immune Disord Drug Targets. (2015)

Search results

Items: 1 to 20 of 5027

1.

Process optimization, biocompatibility and anti-cancer efficacy of curcumin loaded gelatin microparticles cross-linked with dialdeyhde carboxymethyl cellulose.

Kocer Z, Aru B, Aydemir Sezer U, Yanıkkaya Demirel G, Beker U, Sezer S.

J Microencapsul. 2019 Jul 18:1-39. doi: 10.1080/02652048.2019.1646337. [Epub ahead of print]

PMID:
31318306
2.

Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model.

Teng CF, Yu CH, Chang HY, Hsieh WC, Wu TH, Lin JH, Wu HC, Jeng LB, Su IJ.

Sci Rep. 2019 Jul 17;9(1):10338. doi: 10.1038/s41598-019-46891-5.

3.

The "nano to micro" transition of hydrophobic curcumin crystals leading to in situ adjuvant depots for Au-liposome nanoparticle mediated enhanced photothermal therapy.

Alvi SB, Appidi T, Deepak BP, Rajalakshmi PS, Minhas G, Singh SP, Begum A, Bantal V, Srivastava R, Khan N, Rengan AK.

Biomater Sci. 2019 Jul 16. doi: 10.1039/c9bm00932a. [Epub ahead of print]

PMID:
31309204
4.

Protection of wear resistance behaviour of enamel against electron beam irradiation.

Hegde MN, Gatti P, Hegde ND.

BDJ Open. 2019 Jul 11;5:11. doi: 10.1038/s41405-019-0021-0. eCollection 2019.

5.

Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.

Wang WY, Cao YX, Zhou X, Wei B.

Drug Des Devel Ther. 2019 Jul 4;13:2205-2213. doi: 10.2147/DDDT.S205787. eCollection 2019.

6.

Small-molecule compounds target paraptosis to improve cancer therapy.

Wang Y, Wen X, Zhang N, Wang L, Hao D, Jiang X, He G.

Biomed Pharmacother. 2019 Jul 12;118:109203. doi: 10.1016/j.biopha.2019.109203. [Epub ahead of print] Review.

PMID:
31306970
7.

Targeting regulatory T cells by Curcumin: A potential for cancer immunotherapy.

Shafabakhsh R, Pourhanifeh MH, Mirzaei HR, Sahebkar A, Asemi Z, Mirzaei H.

Pharmacol Res. 2019 Jul 12:104353. doi: 10.1016/j.phrs.2019.104353. [Epub ahead of print] Review.

PMID:
31306775
8.

Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma.

Heenatigala Palliyage G, Singh S, Ashby CR Jr, Tiwari AK, Chauhan H.

AAPS PharmSciTech. 2019 Jul 11;20(6):250. doi: 10.1208/s12249-019-1457-1.

PMID:
31297635
9.

Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer.

Tan BL, Norhaizan ME.

Molecules. 2019 Jul 10;24(14). pii: E2527. doi: 10.3390/molecules24142527. Review.

10.

Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer.

Paulraj F, Abas F, H Lajis N, Othman I, Naidu R.

Biomolecules. 2019 Jul 10;9(7). pii: E270. doi: 10.3390/biom9070270. Review.

11.

Polymorphic Transformation of Drugs Induced by Glycopolymeric Vesicles Designed for Anti-Cancer Therapy Probed by Solid-State NMR Spectroscopy.

Prochazkova E, Cao C, Rawal A, Dracinsky M, Bhattacharyya S, Cisarova I, Hook JM, Stenzel MH.

ACS Appl Mater Interfaces. 2019 Jul 10. doi: 10.1021/acsami.9b05514. [Epub ahead of print]

PMID:
31290309
12.

Radiosensitization effects of curcumin plus cisplatin on non-small cell lung cancer A549 cells.

Cai Y, Sheng Z, Liang S.

Oncol Lett. 2019 Jul;18(1):529-534. doi: 10.3892/ol.2019.10364. Epub 2019 May 17.

13.

Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in Breast Cancer Cells.

Güney Eskiler G, Deveci Özkan A, Kaleli S, Bilir C.

J Pharm Pharm Sci. 2019;22(1):281-291. doi: 10.18433/jpps30493.

14.

Inhibitory Traits of Dendrosome Curcumin (DNC) on Breast Cancer Compared to Curcumin Single Compound.

Alghanimi YK, Ghasemian A.

J Gastrointest Cancer. 2019 Jul 9. doi: 10.1007/s12029-019-00273-2. [Epub ahead of print]

PMID:
31286422
15.

Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics.

Parashar K, Sood S, Mehaidli A, Curran C, Vegh C, Nguyen C, Pignanelli C, Wu J, Liang G, Wang Y, Pandey S.

Molecules. 2019 Jul 6;24(13). pii: E2483. doi: 10.3390/molecules24132483.

16.

Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review.

Mokbel K, Mokbel K.

In Vivo. 2019 Jul-Aug;33(4):983-997. doi: 10.21873/invivo.11568. Review.

PMID:
31280187
17.

Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism.

Limanaqi F, Biagioni F, Busceti CL, Ryskalin L, Polzella M, Frati A, Fornai F.

Int J Mol Sci. 2019 Jul 3;20(13). pii: E3274. doi: 10.3390/ijms20133274. Review.

18.

Curcumin Induces Apoptotic Cell Death via Inhibition of PI3-Kinase/AKT Pathway in B-Precursor Acute Lymphoblastic Leukemia.

Kuttikrishnan S, Siveen KS, Prabhu KS, Khan AQ, Ahmed EI, Akhtar S, Ali TA, Merhi M, Dermime S, Steinhoff M, Uddin S.

Front Oncol. 2019 Jun 19;9:484. doi: 10.3389/fonc.2019.00484. eCollection 2019.

19.

Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling.

Da W, Zhang J, Zhang R, Zhu J.

Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419861600. doi: 10.1177/2058738419861600.

20.

Curcumin and its analogues protect from endoplasmic reticulum stress: Mechanisms and pathways.

Shakeri A, Zirak MR, Wallace Hayes A, Reiter R, Karimi G.

Pharmacol Res. 2019 Jun 29;146:104335. doi: 10.1016/j.phrs.2019.104335. [Epub ahead of print] Review.

PMID:
31265891

Supplemental Content

Loading ...
Support Center